Oncology / Cancer Drug
UpdatedBiological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies). Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020.
More Discussions:
My brother died after taking Stivarga for one month. I want to know how many people this happened too. ## Hi Jean, Sorry...
2 REPLIESMy Mother in law was diagnosed with breast cancer and she was at the point of death, with cancer of the Breast in its fi...
2 REPLIEStaking sutent along with radiation treatments for tumor in lower lumbar region what kind of aide effects are most common...
2 REPLIESMy boyfriend was diagnosed with small cell carcinoma in August while in the hospital with pneumonia. Straight out of the...
1 REPLYThere has been some evidence prussian blue is an effective non-toxic fermentation blocker. This would suggest hexacyanof...
Why is hsi giving people the idea that it is a mircle drug, when it cures nothing? All that i see is that it does makes ...
10 REPLIESMy grandfather went to the doctor and was told that he was most likely going to get leukemia. He is already diabetic and...
3 REPLIESyellow oval #93 one side #32 other side ## It is Oxycodone 40mg extended release. Generic for OxyContin 40. It is a narc...
2 REPLIESMy mother found this HSI site and was very excited. She died of cancer, with no discernible change to the progression of...
1 REPLYHi I'm a stage 4 cancer patient. My doctor recently retired after 5 years without telling any of his patients! So ri...
1 REPLY